Sherry Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sherry Yang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Zachary Neubauer
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University , Philadelphia, PA
3 shared publications - Angela Zaladonis
Department of Dermatology and Cutaneous Biology Thomas Jefferson University Philadelphia Pennsylvania USA
2 shared publications - Thinh Q. Nguyen
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University , Philadelphia, PA
2 shared publications - Thomas Z. Rohan
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
2 shared publications Alex Sherban
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
1 shared publicationBs Christina Huang
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
1 shared publication
Latest Publications
- Open Access
- 2 September 2026
- Published by Oxford University Press (OUP) in Skin Health and Disease
Dermatology residency education in the treatment of testosterone-induced acne and androgenic alopecia in trans men: a cross-sectional survey of academic dermatologists in the USA
This cross-sectional survey study explores the experience, comfort and knowledge of dermatology residents and attendings in managing testosterone-induced acne (TiAV) and androgenic alopecia (TiAGA) in trans men. While most respondents reported some level of comfort treating these conditions, objective knowledge scores were modest and revealed gaps across both conditions, particularly TiAGA. Our findings suggest that current LGBTQIA+-focused education may be perceived as adequate but may not translate into knowledge retention or clinical preparedness.
- 2 September 2026
- Published by Oxford University Press (OUP) in Skin Health and Disease
Open AccessDermatology residency education in the treatment of testosterone-induced acne and androgenic alopecia in trans men: a cross-sectional survey of academic dermatologists in the USA
This cross-sectional survey study explores the experience, comfort and knowledge of dermatology residents and attendings in managing testosterone-induced acne (TiAV) and androgenic alopecia (TiAGA) in trans men. While most respondents reported some level of comfort treating these conditions, objective knowledge scores were modest and revealed gaps across both conditions, particularly TiAGA. Our findings suggest that current LGBTQIA+-focused education may be perceived as adequate but may not translate into knowledge retention or clinical preparedness.
- 11 February 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1)
No association between isotretinoin and hypertrophic scar/keloid: a retrospective cohort study of acne patients
- 11 February 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1)
No association between isotretinoin and hypertrophic scar/keloid: a retrospective cohort study of acne patients
- 1 November 2025
- Published by SAGE Publications in Dermatitis®
- Vol. 36 (6) , 650-652
No Evidence of Paradoxical Atopy in Psoriasis Treated with Biologics: A Retrospective Cohort Study
- 1 November 2025
- Published by SAGE Publications in Dermatitis®
- Vol. 36 (6) , 650-652
No Evidence of Paradoxical Atopy in Psoriasis Treated with Biologics: A Retrospective Cohort Study
- Open Access
- 27 August 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 65, 77-79
An immunocompromised patient with cicatricial alopecia
- 27 August 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 65, 77-79
Open AccessAn immunocompromised patient with cicatricial alopecia
- 1 April 2025
- Published by Frontline Medical Communications, Inc. in Cutis
- Vol. 115 (4) , 116-118
A Review of Online Search Tools to Identify Funded Dermatology Away Rotations for Underrepresented Medical Students
Almost all medical students applying to dermatology residency will participate in an away rotation at an outside institution. In this study, we investigated the available search tools created to find rotations that cover costs for underrepresented in medicine (URiM) students and compared them to Google's search results and official program sites to elucidate their utility. A cross-sectional analysis of the Visiting Student Learning Opportunities (VSLO) Visiting Scholars Resources Database and the Funded Away Rotations for Minority Medical Students (FARMS) database was conducted for all programs with the term dermatology under the specialty column and listings tagged for dermatology. We also conducted a Google search by institution name using the phrase underrepresented in medicine dermatology away rotation. All queries were performed from October 24 to October 26, 2024. Our results suggest that the current search databases do not list most of the already limited funded rotation opportunities available for URiM students. Our findings emphasize a need for a centralized, comprehensive, and well-organized database to improve equity of opportunity in the dermatology rotation application search process and further diversify the specialty.
- 1 April 2025
- Published by Frontline Medical Communications, Inc. in Cutis
- Vol. 115 (4) , 116-118
A Review of Online Search Tools to Identify Funded Dermatology Away Rotations for Underrepresented Medical Students
Almost all medical students applying to dermatology residency will participate in an away rotation at an outside institution. In this study, we investigated the available search tools created to find rotations that cover costs for underrepresented in medicine (URiM) students and compared them to Google's search results and official program sites to elucidate their utility. A cross-sectional analysis of the Visiting Student Learning Opportunities (VSLO) Visiting Scholars Resources Database and the Funded Away Rotations for Minority Medical Students (FARMS) database was conducted for all programs with the term dermatology under the specialty column and listings tagged for dermatology. We also conducted a Google search by institution name using the phrase underrepresented in medicine dermatology away rotation. All queries were performed from October 24 to October 26, 2024. Our results suggest that the current search databases do not list most of the already limited funded rotation opportunities available for URiM students. Our findings emphasize a need for a centralized, comprehensive, and well-organized database to improve equity of opportunity in the dermatology rotation application search process and further diversify the specialty.
- Open Access
- 9 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1110
Hidradenitis Suppurativa Is Associated with an Increased Risk of Adverse Cardiac Events and All-Cause Mortality
Background: Hidradenitis suppurativa (HS) has been previously associated with greater rates of major adverse cardiac events (MACEs) compared to the general population. This study aims to better elucidate the association between HS, MACEs, and other cardiovascular diseases. Methods: We utilized TriNetX, a global database of electronic health records, to conduct a retrospective cohort study. HS patients were matched on demographic and cardiovascular disease risk factors to both healthy and psoriasis groups as controls. Results: After adjusting for cardiovascular disease risk factors, HS patients had a relative risk (RR) (95% CI) of 2.06 (1.83–2.32) for myocardial infarction, 1.62 (1.44–1.82) for ischemic stroke, 2.21 (2.04–2.40) for heart failure, 1.95 (1.84–2.07) for MACEs, and 2.57 (2.34–2.83) for all-cause mortality compared to healthy controls. When comparing HS patients to matched psoriasis controls, HS patients had an RR of 1.31 (1.17–1.47) for myocardial infarction, 1.04 (0.93–1.16) for ischemic stroke, 1.24 (1.15–1.34) for heart failure, 1.16 (1.09–1.22) for MACEs, and 1.38 (1.27–1.5) for all-cause mortality. Herein, we demonstrate that patients with HS have increased rates of all cardiovascular diseases investigated when compared to healthy and psoriasis controls, even after adjusting for cardiovascular disease risk factors. Conclusions: These findings highlight the potential benefit in screening for and managing modifiable cardiovascular risk factors in HS patients.
- 9 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1110
Open AccessHidradenitis Suppurativa Is Associated with an Increased Risk of Adverse Cardiac Events and All-Cause Mortality
Background: Hidradenitis suppurativa (HS) has been previously associated with greater rates of major adverse cardiac events (MACEs) compared to the general population. This study aims to better elucidate the association between HS, MACEs, and other cardiovascular diseases. Methods: We utilized TriNetX, a global database of electronic health records, to conduct a retrospective cohort study. HS patients were matched on demographic and cardiovascular disease risk factors to both healthy and psoriasis groups as controls. Results: After adjusting for cardiovascular disease risk factors, HS patients had a relative risk (RR) (95% CI) of 2.06 (1.83–2.32) for myocardial infarction, 1.62 (1.44–1.82) for ischemic stroke, 2.21 (2.04–2.40) for heart failure, 1.95 (1.84–2.07) for MACEs, and 2.57 (2.34–2.83) for all-cause mortality compared to healthy controls. When comparing HS patients to matched psoriasis controls, HS patients had an RR of 1.31 (1.17–1.47) for myocardial infarction, 1.04 (0.93–1.16) for ischemic stroke, 1.24 (1.15–1.34) for heart failure, 1.16 (1.09–1.22) for MACEs, and 1.38 (1.27–1.5) for all-cause mortality. Herein, we demonstrate that patients with HS have increased rates of all cardiovascular diseases investigated when compared to healthy and psoriasis controls, even after adjusting for cardiovascular disease risk factors. Conclusions: These findings highlight the potential benefit in screening for and managing modifiable cardiovascular risk factors in HS patients.
- 30 December 2024
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 29 (3) , 259-262
Pain Self-Management Strategies for Hidradenitis Suppurativa Patients: An In-Person Survey Study
Background: Pain is an undermanaged symptom of hidradenitis suppurativa (HS). Relatively few studies have investigated at-home pain management measures HS patients use, the efficacy of these measures, and how they may correlate with disease severity. Objectives: The objective of this study is to survey pain management strategies used by HS patients and evaluate their efficacy. Methods: We conducted a survey study on patients with HS from April 2023 to April 2024 at the Hidradenitis Suppurativa Clinic at Thomas Jefferson University Hospital (Philadelphia, PA). We measured the usage of certain pain management options in the past year for HS patients and asked patients to rank their pain relief from each measure on a Likert scale. We also recorded the clinically determined Hurley stage for HS severity to study correlations between the Hurley stage and pain management methods used/efficacy. Results: Surveyed patients (n = 63) indicated a preference for over-the-counter (OTC) and topical pain management measures. For higher Hurley stages, rates of cannabis or prescription pain management usage were higher. Patients with Hurley stage III reported significantly greater relief from prescription opioid and non-opioid medications when compared to oral OTC medications; however, the degree of relief was considerably less than that obtained by patients with milder disease. Conclusion: Pain management can be challenging for HS patients, especially among those with higher disease severity. Of note, altered pain pathways in HS could contribute to the reduced effect of pain relief methods in more severe stages.
- 30 December 2024
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 29 (3) , 259-262
Pain Self-Management Strategies for Hidradenitis Suppurativa Patients: An In-Person Survey Study
Background: Pain is an undermanaged symptom of hidradenitis suppurativa (HS). Relatively few studies have investigated at-home pain management measures HS patients use, the efficacy of these measures, and how they may correlate with disease severity. Objectives: The objective of this study is to survey pain management strategies used by HS patients and evaluate their efficacy. Methods: We conducted a survey study on patients with HS from April 2023 to April 2024 at the Hidradenitis Suppurativa Clinic at Thomas Jefferson University Hospital (Philadelphia, PA). We measured the usage of certain pain management options in the past year for HS patients and asked patients to rank their pain relief from each measure on a Likert scale. We also recorded the clinically determined Hurley stage for HS severity to study correlations between the Hurley stage and pain management methods used/efficacy. Results: Surveyed patients (n = 63) indicated a preference for over-the-counter (OTC) and topical pain management measures. For higher Hurley stages, rates of cannabis or prescription pain management usage were higher. Patients with Hurley stage III reported significantly greater relief from prescription opioid and non-opioid medications when compared to oral OTC medications; however, the degree of relief was considerably less than that obtained by patients with milder disease. Conclusion: Pain management can be challenging for HS patients, especially among those with higher disease severity. Of note, altered pain pathways in HS could contribute to the reduced effect of pain relief methods in more severe stages.
- 26 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors
- 26 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors
- 16 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
Rates of sepsis among patients hospitalized for hidradenitis suppurativa
- 16 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
Rates of sepsis among patients hospitalized for hidradenitis suppurativa
- 23 February 2022
- Published by Taylor & Francis
- p. 200-211
Wound Healing, Ulcers, and Scars
Definition: Wound healing is a fundamental process that is triggered by acute tissue injury to the epidermal or dermal layers.
- 23 February 2022
- Published by Taylor & Francis
- p. 200-211
Wound Healing, Ulcers, and Scars
Definition: Wound healing is a fundamental process that is triggered by acute tissue injury to the epidermal or dermal layers.